Medical Xpress September 25, 2024
Virologist Rúbens Alves, Ph.D., came to La Jolla Institute for Immunology (LJI) to contribute to life-saving vaccine research. As a member of LJI’s Shresta Lab, Alves studied how T cells fight viruses such as SARS-CoV-2 (which causes COVID-19) and dengue virus.
As a postdoctoral researcher at LJI, Alves published important findings in Nature Communications that shed light on how the immune system cross-reacts to SARS-CoV-2 and common cold coronaviruses. In 2023, he also co-led the team that won top honors in the Nucleate Activator competition for a proposal to advance dengue and Zika virus vaccine strategies.
Alves recently returned to his home country of Brazil to serve as a principal investigator (PI) at the Institut Pasteur de São Paulo. He...
Today's Sponsors
Today's Sponsor